Attovia Therapeutics, Inc. (ATTO) stock
ATTONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026
$14.86+0.13 (+0.92%)
Close on Nov 17, 2026Market cap $678.38MP/E –Yield –
Attovia Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Attovia Therapeutics's total assets was $411.82M at Sep 30, 2026. For fiscal 2025 it was $165.89M.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $165.89M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $411.82M | – |
| Q2 FY2026 | Jun 30, 2026 | $128.35M | – |
| Q4 FY2025 | Dec 31, 2025 | $165.89M | – |
See a number that looks wrong?